Thu, 21 Mar 2019 14:47:18: Could proxy advisers sway investors to vote ‘no’ on BMS-Celgene merger?

Thu, 21 Mar 2019 14:15:50: Where can Biogen turn after mammoth Alzheimer's blow? The M&A table, analysts say

Thu, 21 Mar 2019 13:53:50: Jazz scores FDA nod for sleepiness drug Sunosi, but a launch will have to wait

Thu, 21 Mar 2019 12:17:22: FDA temporarily retreats from impurity standards as losartan shortages loom

Wed, 20 Mar 2019 17:44:06: C2 Pharma doubles down on supplies of digoxin API

Wed, 20 Mar 2019 15:09:17: Merck KGaA investing €1B at headquarters site as part of 5-year work agreement

Wed, 20 Mar 2019 15:08:55: Novo Nordisk, aiming for approval this fall, puts first-ever oral GLP-1 drug up for FDA review

Wed, 20 Mar 2019 13:40:40: AbbVie faces class action lawsuit from New York grocery union over Humira 'patent thicket'

Wed, 20 Mar 2019 12:44:02: Thermo Fisher expands biologics manufacturing at 3 sites

Wed, 20 Mar 2019 12:32:05: See ya, Goodfella: #FierceMadness voters bounce Liotta, Tremfya and more in first-round play

Wed, 20 Mar 2019 06:17:35: Pfizer, Merck KGaA scrap yet another Bavencio ovarian cancer trial

Wed, 20 Mar 2019 02:26:28: Merck's refreshed HPV vaccine push puts Mom in the spotlight

Tue, 19 Mar 2019 18:04:45: Sage wins OK for depression drug Zulresso. Up next? Major marketing challenges

Tue, 19 Mar 2019 15:18:14: Venclexta trial deaths force AbbVie, Roche to stop recruiting myeloma patients

Tue, 19 Mar 2019 15:14:50: Without 'smoking gun,' BMS, Celgene deal will close as planned: analyst

Tue, 19 Mar 2019 14:16:17: Bayer animal health sale could rake in $8B and bids from private equity: report

Tue, 19 Mar 2019 14:01:13: In another I-O first for Roche, Tecentriq nabs blockbuster small cell lung cancer nod

Tue, 19 Mar 2019 13:46:41: Mylan and Hospira both recall injected drugs after particulate discovered in vials

Tue, 19 Mar 2019 13:10:25: Lilly's $7M tax abatement in Indianapolis draws bipartisan pushback: reports

Mon, 18 Mar 2019 19:00:22: Who'll follow Sanofi CEO Olivier Brandicourt? The company's eyeing candidates now

Mon, 18 Mar 2019 15:33:25: Gilead's ex-CEO John Milligan picked up $26M pay package on his way out

Mon, 18 Mar 2019 14:16:25: Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?

Mon, 18 Mar 2019 13:54:31: Spectrum’s Neulasta competitor tripped up by manufacturing issues

Mon, 18 Mar 2019 12:10:25: ACC: Amarin rolls out more Vascepa heart benefits data to back label expansion

Mon, 18 Mar 2019 12:03:36: ACC: AstraZeneca's Farxiga chops follow-up CV events by 16% in heart attack patients with diabetes